Stock Analyses

Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.

All sectors 6,479 Financial Services 1,900 Healthcare 1,116 Technology 1,079 Industrials 668 Consumer Cyclical 490 Basic Materials 337 Consumer Defensive 248 Communication Services 213 Utilities 183 Energy 165 Real Estate 80
Clear
6,990 stocks · page 117 of 117
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ZH
Zhihu Inc.
Deeply overvalued
Technology
Price$2.84
Model IV$1.34
P/IV2.20
Premium +112% Return to IV: -52.8%
Market implies +10.5%/yr vs model +2.0% · above model
ZIM
ZIM Integrated Shipping Services Ltd.
Deeply undervalued
Industrials
Price$29.57
Model IV$46.10
P/IV0.59
Discount 36% Return to IV: +55.9%
Market implies -7.3%/yr vs model +2.0% · below model
ZION
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
Fairly valued
Financial Services
Price$68.75
Model IV$60.07
P/IV1.04
Premium +14% Return to IV: -12.6%
ZIONP
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
Deeply undervalued
Financial Services
Price$18.15
Model IV$75.45
P/IV0.26
Discount 76% Return to IV: +315.7%
ZIP
ZIPRECRUITER, INC.
Deeply overvalued
Technology
Price$3.86
Model IV$2.54
P/IV1.27
Premium +52% Return to IV: -34.2%
Market implies +11.0%/yr vs model +2.0% · above model
ZJK
ZJK Industrial Co., Ltd.
Fairly valued
Industrials
Price$2.28
Model IV$2.89
P/IV1.00
Discount 21% Return to IV: +26.8%
Market implies +12.5%/yr vs model +23.7% · below model
ZJYL
Jin Medical International Ltd.
Valuation N/A
Healthcare
Price$2.07
Model IV—
P/IV—
Market implies +54.5%/yr vs model +2.0% · above model
ZKH
ZKH Group Ltd
Valuation N/A
Consumer Cyclical
Price$2.91
Model IV—
P/IV—
ZKIN
ZK International Group Co., Ltd.
Valuation N/A
Industrials
Price$1.12
Model IV—
P/IV—
Market implies +69.8%/yr vs model +2.0% · above model
ZKP
Lafayette Digital Acquisition Corp. I
Valuation N/A
Financial Services
Price$10.05
Model IV—
P/IV—
ZKPU
Lafayette Digital Acquisition Corp. I
Valuation N/A
Financial Services
Price$10.03
Model IV—
P/IV—
ZKPW
Lafayette Digital Acquisition Corp. I
Valuation N/A
Financial Services
Price$0.31
Model IV—
P/IV—
ZLAB
Zai Lab Ltd
Valuation N/A
Healthcare
Price$24.14
Model IV—
P/IV—
Market implies +37.3%/yr vs model +33.5% · above model
ZM
Zoom Communications, Inc.
Deeply overvalued
Technology
Price$95.57
Model IV$66.82
P/IV1.52
Premium +43% Return to IV: -30.1%
Owner yield 5.9% 10-yr IRR 10.9% · moderate
Market implies +10.5%/yr vs model +6.7% · above model
ZNB
Zeta Network Group
Valuation N/A
Consumer Defensive
Price$1.41
Model IV—
P/IV—
Market implies -12.9%/yr vs model +6.5% · below model
ZNTL
Zentalis Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$3.51
Model IV—
P/IV—
Market implies +22.0%/yr vs model +15.0% · above model
ZONE
CleanCore Solutions, Inc.
Valuation N/A
Consumer Defensive
Price$0.15
Model IV—
P/IV—
Market implies +47.3%/yr vs model +29.2% · above model
ZOOZ
ZOOZ Strategy Ltd.
Valuation N/A
Industrials
Price$7.32
Model IV—
P/IV—
ZS
Zscaler, Inc.
Fairly valued
Technology
Price$191.73
Model IV$174.48
P/IV0.80
Premium +10% Return to IV: -9.0%
Market implies -0.7%/yr vs model +41.2% · below model
ZSL
ProShares Trust II
Deeply overvalued
Financial Services
Price$24.52
Model IV$12.62
P/IV2.33
Premium +94% Return to IV: -48.5%
ZSQR
Z Squared Inc.
Valuation N/A
Financial Services
Price$3.07
Model IV—
P/IV—
Market implies +15.3%/yr vs model +50.0% · below model
ZTO
ZTO Express (Cayman) Inc.
Deeply undervalued
Industrials
Price$20.90
Model IV$36.29
P/IV0.61
Discount 42% Return to IV: +73.6%
Owner yield 5.4% 10-yr IRR 11.4% · moderate
Market implies +0.5%/yr vs model +8.9% · below model
ZTR
Virtus Total Return Fund Inc.
Valuation N/A
Unknown
Price$6.60
Model IV—
P/IV—
ZTS
Zoetis Inc.
Undervalued
Healthcare
Price$71.40
Model IV$88.64
P/IV0.91
Discount 19% Return to IV: +24.1%
Owner yield 5.7% 10-yr IRR 11.9% · moderate
Market implies +4.1%/yr vs model +8.7% · below model
ZUMZ
Zumiez Inc
Valuation N/A
Consumer Cyclical
Price$14.55
Model IV—
P/IV—
Market implies +21.1%/yr vs model +2.3% · above model
ZURA
Zura Bio Ltd
Valuation N/A
Healthcare
Price$5.21
Model IV—
P/IV—
ZVRA
ZEVRA THERAPEUTICS, INC.
Fairly valued
Healthcare
Price$12.05
Model IV$12.28
P/IV0.94
Discount 2% Return to IV: +1.9%
Market implies -5.2%/yr vs model +38.8% · below model
ZWS
Zurn Elkay Water Solutions Corp
Fairly valued
Industrials
Price$46.18
Model IV$44.62
P/IV1.05
Premium +3% Return to IV: -3.4%
Market implies +11.1%/yr vs model +13.6% · in line
ZYBT
Zhengye Biotechnology Holding Ltd
Deeply overvalued
Healthcare
Price$1.55
Model IV$0.39
P/IV2.18
Premium +297% Return to IV: -74.8%
Market implies +24.0%/yr vs model +10.0% · above model
ZYME
Zymeworks Inc.
Deeply overvalued
Healthcare
Price$26.24
Model IV$8.98
P/IV2.80
Premium +192% Return to IV: -65.8%
Market implies +9.7%/yr vs model +41.2% · below model